Advanced search
Publication Cover
Pediatric Hematology and Oncology Volume 17, 2000 - Issue 2
Submit an article Journal homepage
25
Views
1
CrossRef citations to date
0
Altmetric
Research Article

NATURAL KILLER CELL NUMBERS AND CYTOTOXIC ACTIVITY IN PEDIATRIC HODGKIN DISEASE

Aydan Ikinciogullari Department of Pediatric Immunology–Allergy, Ankara University Medical School, Ankara, Turkey
,
Figen Dogu Department of Pediatric Immunology–Allergy, Ankara University Medical School, Ankara, Turkey
,
Emel Babacan Department of Pediatric Immunology–Allergy, Ankara University Medical School, Ankara, Turkey
,
Gul Oflaz Department of Nuclear Medicine, Ankara University Medical School, Ankara, Turkey
,
Ulya Ertem Dr. Sami Ulus Children‘s Hospital, Ankara, Turkey
,
Gulsan Yavuz Department of Pediatric Hematology–Oncology, Ankara University Medical School, Ankara, Turkey
,
Emel Unal Department of Pediatric Hematology–Oncology, Ankara University Medical School, Ankara, Turkey
,
Sevgi Gozdasoglu Department of Pediatric Hematology–Oncology, Ankara University Medical School, Ankara, Turkey
,
Nurdan Tacyildiz Department of Pediatric Hematology–Oncology, Ankara University Medical School, Ankara, Turkey
,
Ayhan Dagdemir Dr. Sami Ulus Children‘s Hospital, Ankara, Turkey
&
Ayhan O. Cavdar Department of Pediatric Hematology–Oncology, Ankara University Medical School, Ankara, Turkey
 show all
Pages 133-139 | Published online: 09 Jul 2009

REFERENCES

  • cavdar AO, Taçoy A, Babacan E, et al. Hodgkin's disease in Turkish children: a clinical and histopatho-logic analysis. J Natl Cancer Inst. 1977;58:479–481.
  • Bergmann L, Mitrou PS, Demmer-Dieckmann M, Ruhmann Fl, Weidemann E. Impaired T and B cell functions in patients with Hodgkin's disease. Cancer Immunol Immunother. 1987;25:59–64.
  • Slivnick DJ, Elus TM, Nawrocki JF, Fisher RI. The impact of Hodgkin's disease on the immune system. Semin Oncol. 1990;7:673–682.
  • Gruss HJ, Pinto A, Duyster J, Poppema S, Herrmann F. Hodgkin's disease: a tumor with disturbed immunological pathways. Immunol Today. 1997;18:156–163.
  • Tullgren 0, Grimfors G, Holm G, et al. Lymphocyte abnormalities predicting a poor prognosis in Hodgkin's disease. Cancer. 1991;68:768–778.
  • Strayer DR, Carter WA, Mayberry SD, Pequignot E, Brodsky I. Low natural cytotoxicity of peripheral blood mononuclear cells in individuals with high familial incidences of cancer. Cancer Res. 1984; 44:370–374.
  • Lukes RJ, Craver F, Hall TC, Rappaport H, Rubin T. Report of the Nomenclature Committee. Cancer Res. 1966;26:1311.
  • Carbone PP, Kaplan HS, Mushoff K, Smithers DW, Tubiana M. Report of the Committee of Hodgkin's Disease Staging Classification. Cancer Res. 1971;31:1860–1861.
  • Jhaver KG, Advani SH, Nadkarni1J. Generation and characterization of lymphokine-activated killer cells from non-Hodgkin's lymphoma patients. Immunol Lett. 1990;24:217–224.
  • Lauria F, Foa R, Gobbi M, et al. Increased proportion of suppressor/cytotoxic (OKT8 ±)cells in patients with Hodgkin's disease in long-lasting remission. Cancer. 1983;52:1385–1388.
  • Brittenden J, Heys SD, Ross J, Eremin 0. Natural killer cells and cancer. Cancer. 1996;77:1226–1243.
  • Komiyama A, Kawai H, Yamada S, et al. A killing defect of natural killer cells with the absence of natural killer cytotoxic factors in a child with Hodgkin's disease. Blood. 1987;69:1686–1690.
  • Douer D, Shaked N, Ramot B. Normal natural killer cell activity in Hodgkin's disease patients in remission. Clin Exp Immunol. 1987;69:660–667.
  • Frydecka I. Natural killer cell activity during the course of disease in patients with Hodgkin's disease. Cancer 1985;56:2799–2803.
  • Gastl G, Niederwieser D, Marth C, et al. Human large granuler lymphocytes and their relationship to natural killer cell activity in various disease states. Blood. 1984;67:288–295.
  • Healy F, Rees R, Hancock BW. An assessment of natural cell mediated cytotoxicity in patients with malignant lymphoma. Eur J Cancer Clin Oncol. 1985;21:775–783.
  • Robertson MJ, Ritz J. Biology and clinical releavence of human natural killer cells. Blood. 1990;76: 2421–2438.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.